Eli Lilly

YTD

ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

47,000

Employees47,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

47,000

Employees47,000

LLY Key Statistics

Market cap

872.39B

Market cap872.39B

Price-Earnings ratio

78.59

Price-Earnings ratio78.59

Dividend yield

0.59%

Dividend yield0.59%

Average volume

3.60M

Average volume3.60M

High today

$921.49

High today$921.49

Low today

$919.00

Low today$919.00

Open price

$903.35

Open price$903.35

Volume

5.42K

Volume5.42K

52 Week high

$972.53

52 Week high$972.53

52 Week low

$711.40

52 Week low$711.40

LLY News

Quartz 3d

Eli Lilly comes for knockoff weight loss drugs in new ad campaign

Eli Lilly (LLY-0.23% ) , the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about off-brand...

Seeking Alpha 3d

Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the com...

Quartz 3d

Eli Lilly's big investment, cheaper Zepbound, and Hims & Hers' options: Pharma news roundup

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also made a wider range of doses of its b...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

13.3%

Sell

3.3%

More LLY News

Simply Wall St 4d

Eli Lilly Expands US Production With US$50 Billion Investment Creating 3000 Jobs

In a significant move, recently announced plans to expand its domestic medicine production with four new manufacturing sites, reflecting its commitment to a tot...

Quartz 4d

Eli Lilly plans to make drugs in America. First, it wants a tax cut

Eli Lilly (LLY+0.84% ) , the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new manufacturi...

Benzinga 5d

Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target

At a press conference in Washington, D.C., Eli Lilly And Co LLY announced its plans to bolster its domestic medicine production across therapeutic areas by buil...

Seeking Alpha 5d

Eli Lilly to boost U.S. manufacturing footprint amid Trump’s tariff threats

Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on Wednesday, amid President Donald Trump’...

Simply Wall St 5d

We Think Eli Lilly's Profit Is Only A Baseline For What They Can Achieve

The subdued stock price reaction suggests that Eli Lilly and Company's ( ) strong earnings didn't offer any surprises. Our analysis suggests that investors migh...

TipRanks 5d

Major Stock Sale Shakes Up Eli Lilly & Co Ownership!

New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on February 26, 2025. Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has re...

TipRanks 6d

Organovo’s FXR program to be acquired by Eli Lilly

Organovo (ONVO) Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314. Under this transactio...